抗细菌
噻唑
结核分枝杆菌
互补
组氨酸
化学
酶
生物化学
非竞争性抑制
EC50型
立体化学
转移酶
IC50型
体外
突变体
肺结核
基因
医学
病理
作者
Tejas M. Dhameliya,Rishu Tiwari,Arkaprabha Banerjee,Sahaj Pancholia,Dharmarajan Sriram,Dulal Panda,Asit K. Chakraborti
标识
DOI:10.4155/fmc-2022-0226
摘要
Aims: The screening of antimycobacterial benzo[d]thiazole-2-carboxamides against ATP-phosphoribosyl transferase (ATP-PRTase) was conducted. Materials & methods: The antitubercular potential of compounds 1 and 2 against ATP-PRTase was assessed through the determination of half maximal effective concentration (EC50) and binding constant (Kd), as well as competitive inhibitory studies and studies of perturbation of secondary structure, molecular modeling and L-histidine complementation assay. Results & conclusion: Compounds 1n and 2a significantly inhibited ATP-PRTase as evidenced by their EC50 and Kd values and the perturbation of the secondary structure study. Compound 1n exhibited stronger competitive inhibition toward ATP compared with 2a. The inhibition of the growth of Mycobacterium tuberculosis by targeting the L-histidine biosynthesis pathway and molecular modeling studies further supported the inhibition of ATP-PRTase.
科研通智能强力驱动
Strongly Powered by AbleSci AI